MAB1910
Anti-Collagen Type IV α 2 Chain Antibody, clone 23IIC3
ascites fluid, clone 23IIC3, Chemicon®
Synonym(s):
Anti-BSVD2, Anti-ICH, Anti-POREN2
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
UNSPSC Code:
12352203
eCl@ss:
32160702
NACRES:
NA.41
Recommended Products
biological source
mouse
Quality Level
antibody form
ascites fluid
antibody product type
primary antibodies
clone
23IIC3, monoclonal
species reactivity
monkey, human, rat
manufacturer/tradename
Chemicon®
technique(s)
ELISA: suitable
immunohistochemistry: suitable (paraffin)
western blot: suitable
isotype
IgG1
UniProt accession no.
shipped in
dry ice
target post-translational modification
unmodified
Gene Information
human ... COL4A2(1284)
Specificity
Recognizes Human type IV collagen, alpha-2 chains.
Immunogen
Human amniotic type IV collagen
Application
Detect Collagen Type IV α 2 Chain using this Anti-Collagen Type IV α 2 Chain Antibody, clone 23IIC3 validated for use in ELISA, IH(P) & WB.
Immunohistochemistry: 1:500, acetone fixed, frozen tissue recommended. Weak reactivity on on formalin fixed, paraffin sections (1:100) after treatment with 1% trypsin (20 minutes, room temperature). Or alternatively, 4% PFA fixed, HEIR treated tissue has worked in monkey (Qin, 2003) at 1:200 dilution.
Western blot: 1:500, 170 kDa.
ELISA at 1:200
Optimal working dilutions must be determined by the end user.
Western blot: 1:500, 170 kDa.
ELISA at 1:200
Optimal working dilutions must be determined by the end user.
Research Category
Cell Structure
Cell Structure
Research Sub Category
ECM Proteins
ECM Proteins
Target description
170 kDa
Physical form
Liquid.
Unpurified
Storage and Stability
Maintain for 1 year at -20°C from date of shipment. Aliquot to avoid repeated freezing and thawing. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
Analysis Note
Control
Positive Control: Kidney, muscle, tendon spleen tissue
Negative Control: Neurons/glia
Positive Control: Kidney, muscle, tendon spleen tissue
Negative Control: Neurons/glia
Other Notes
Concentration: Please refer to the Certificate of Analysis for the lot-specific concentration.
Legal Information
CHEMICON is a registered trademark of Merck KGaA, Darmstadt, Germany
Disclaimer
Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Still not finding the right product?
Give our Product Selector Tool a try.
Storage Class
10 - Combustible liquids
wgk_germany
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Certificates of Analysis (COA)
Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Immunolocalization of tight junction proteins in blood vessels in human germinal matrix and cortex.
John A Anstrom,Clara R Thore,Dixon M Moody,William R Brown
Histochemistry and Cell Biology null
Combined inhibition of aromatase activity and dihydrotestosterone supplementation attenuates renal injury in male streptozotocin (STZ)-induced diabetic rats.
Manigrasso, MB; Sawyer, RT; Hutchens, ZM; Flynn, ER; Maric-Bilkan, C
American Journal of Physiology: Renal Physiology null
Laminin-5-enriched extracellular matrix accelerates angiogenesis and neovascularization in association with ePTFE.
Kameha R Kidd, Stuart K Williams
Journal of Biomedical Materials Research Part A null
D Ohlund et al.
British journal of cancer, 101(1), 91-97 (2009-06-06)
Pancreas cancer is a dreaded disease with high mortality, despite progress in surgical and oncological treatments in recent years. The field is hampered by a lack of good prognostic and predictive tumour biomarkers to be used during follow-up of patients.
Reduced ratio of afferent to total vascular density in mesial temporal sclerosis.
Mott RT, Thore CR, Moody DM, Glazier SS, Ellis TL, Brown WR
Journal of Neuropathology and Experimental Neurology null
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service